The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

2018 Awards

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Team Science Awards

Targeting BAP1-dependent alterations in metastatic uveal melanoma

The Helman Family-MRA Team Science Award, 2018-2021

  • Andrew Aplin, Thomas Jefferson University

  • Emily Bernstein, Icahn School of Medicine at Mount Sinai

  • J. William Harbour, Sylvester Comprehensive Cancer Center/University of Miami Health Systems

  • Young Investigator: Marlana Orloff, Thomas Jefferson University

Diet, mental health, and the microbiome in response to immunotherapy

MRA Team Science Award, collaboratively funded by University of Texas MD Anderson Cancer Center, 2018-2021

  • Lorenzo Cohen, University of Texas MD Anderson Cancer Center

  • Jennifer Wargo, University of Texas MD Anderson Cancer Center

  • Young Investigator: Jennifer McQuade, University of Texas MD Anderson Cancer Center

Autophagy in the tumor microenvironment as a target for drug development

The Anna-Maria and Stephen Kellen Foundation-MRA Team Science Award, 2018-2021

  • Hilary Coller, University of California, Los Angeles

  • Beatrice Knudsen, Cedars-Sinai Medical Center

  • Lili Yang, University of California, Los Angeles

  • Young Investigator: Claudio Scafoglio, University of California, Los Angeles

Telomere crisis in acral melanoma: Diagnostic and prognostic potentials

The Black Family-MRA Team Science Award, 2018-2021

  • Titia de Lange, The Rockefeller University

  • Marcin Imielinski, Joan & Sanford I. Weill Medical College of Cornell University

  • Young Investigator: John Maciejowski, Memorial Sloan Kettering Cancer Center

Commensal microbiota and anti-PD-1 efficacy

MRA Team Science Award, collaboratively funded by The University of Chicago, 2018-2021

  • Thomas Gajewski, The University of Chicago

  • Jason Luke, The University of Chicago

  • Cathryn Nagler, The University of Chicago

  • Young Investigator: Riyue Bao, The University of Chicago

Patient focused therapy for acral melanoma

The Sokoloff Family-MRA Team Science Award, with collaborative funding from Memorial Sloan Kettering Cancer Center, 2018-2021

  • Ruth Halaban, Yale University

  • Charlotte Ariyan, Memorial Sloan Kettering Cancer Center

  • Alfred Bothwell, Yale University

  • Jian Cao, Yale University

  • Neal Rosen, Memorial Sloan Kettering Cancer Center

  • Richard White, Memorial Sloan Kettering Cancer Center

  • Jedd Wolchok, Memorial Sloan Kettering Cancer Center

  • Qin Yan, Yale University

  • Young Investigator: Gauri Panse, Yale University

Identifying genetic dependencies in rare forms of melanoma

MRA Team Science Award, 2018-2021

  • Nicholas Hayward, Queensland Institute of Medical Research

  • Francisca Vazquez, Broad Institute

  • Young Investigator: Ken Dutton-Regester, Queensland Institute of Medical Research

Prognostic and functional role of altered circular RNAs in melanoma

Leveraged Finance Fights Melanoma-MRA Team Science Award, 2018-2021

  • Eva Hernando, New York University School of Medicine

  • Ernesto Guccione, Icahn School of Medicine at Mount Sinai

  • Edward and Julie Minskoff – Young Investigator: Melissa Wilson, New York University School of Medicine

Next-generation neoantigen-targeting peptide vaccines for melanoma patients

BJ’s Wholesale Club-MRA Team Science Award, 2018-2021

  • Patrick Ott, Dana-Farber Cancer Institute

  • Bradley Pentelute, Massachusetts Institute of Technology

  • Catherine Wu, Dana-Farber Cancer Institute

  • Young Investigator: Osama Rahma, Dana-Farber Cancer Institute

Regulating telomerase & telomere homeostasis in acral melanoma development

MRA Team Science Award, collaboratively funded by the research institutions, 2018-2021

  • Gavin Robertson, The Pennsylvania State University College of Medicine

  • Jiyue Zhu, Washington State University

  • Young Investigator: De Cheng, Washington State University

  • Young Investigator: Shobhan Gaddameedhi, Washington State University

  • Young Investigator: Raghavendra Gowda, The Pennsylvania State University College of Medicine

Defining and targeting driver events in acral melanoma

U.S. Trust-MRA Team Science Award, 2018-2021

  • Keiran Smalley, H. Lee Moffitt Cancer Center & Research Institute

  • Yian Chen, H. Lee Moffitt Cancer Center & Research Institute

  • John Koomen, H. Lee Moffitt Cancer Center & Research Institute

  • Jane Messina, H. Lee Moffitt Cancer Center & Research Institute

  • Jamie Teer, H. Lee Moffitt Cancer Center & Research Institute

  • Young Investigator, Florian Karreth, H. Lee Moffitt Cancer Center & Research Institute

Directing adaptive immune responses to non-polymorphic MHCs in melanoma

MRA Team Science Award, collaboratively funded by Massachusetts Institute of Technology, 2018-2021

  • Forest White, Massachusetts Institute of Technology-Koch Institute for Integrative Cancer Research

  • Dane Wittrup, Massachusetts Institute of Technology

  • Young Investigator: Michael Birnbaum, Massachusetts Institute of Technology-Koch Institute for Integrative Cancer Research

  • Young Investigator: Stefani Spranger, Massachusetts Institute of Technology-Koch Institute for Integrative Cancer Research

DAMPening immunotherapy adverse events in melanoma

MRA Team Science Award, collaboratively funded by the research institutions, 2018-2021

  • Pan Zheng, University of Maryland, Baltimore

  • Yang Liu, University of Maryland, Baltimore

  • Young Investigator: Siwen Hu-Lieskovan, The University of California, Los Angele

Table of Contents

YOU MAY BE INTERESTED IN

Guest Editorial

Rathmell: We must support our junior colleagues
“Empathy and listening is a key place to start”

Just consider for a minute if this was the first year of running your lab, if you were on the job market as a physician or scientist right now, if you were a resident contemplating a career in cancer research after fellowship, if you were a graduate student or postdoc, if you were an undergraduate or a technician who was looking toward graduate school.
By W. Kimryn Rathmell
Guest Editorial

Weill Cancer Hub East to investigate connections between metabolism and anti-tumor immunity
Weill Cornell, Rockefeller, Princeton and the Ludwig Institute for Cancer Research showcase the power of collaboration

The immune system can be a powerful tool to control cancer. Immune cells within our body detect cancer cells and release payloads that kill them. Transformative science in the last decade has led to the development of therapies that enhance the ability of our immune cells to carry out this function. These therapies, including checkpoint blockade and CAR-T cells, have been lifesaving for many patients that before had untreatable cancer. But, sadly, a majority of patients with advanced solid tumors still succumb to their disease. 
By Jedd D. Wolchok, Joshua D. Rabinowitz and Sohail Tavazoie
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account